Nabumetone Tablet
Product Images NDC 67296-2137

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 67296-2137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

Nabumetone Tablets USP 500 mg oral tablets label showing 100 count package. Label includes directions to dispense accompanying Medication Guide, storage instructions, and child-resistant container notice. Manufactured by ScieGen Pharmaceuticals, Inc. Barcode and NDC 50228-465-01 present on label.*

FDA Label Image

Container2 (Container2)

Label of Nabumetone Tablets, USP 500 mg oral tablets, containing 500 tablets per container. The label includes dispensing instructions and storage guidelines, with the manufacturer identified as ScieGen Pharmaceuticals, Inc. The label features the NDC 50228-465-05 and indicates the product is Rx only.*

FDA Label Image

Container2 (Container3)

Label for Nabumetone Tablets, USP 750 mg. The label includes dosing and storage instructions, a barcode, and states it contains 100 tablets. Manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY. The label also advises dispensing the accompanying medication guide and is marked Rx Only.*

FDA Label Image

Container2 (Container4)

Label for Nabumetone Tablets USP, 750 mg oral tablets. The label indicates a quantity of 500 tablets, Rx only. It shows the manufacturer as ScieGen Pharmaceuticals, Inc. and includes storage instructions along with a warning to keep out of reach of children. A barcode is also visible on the label.*

FDA Label Image

Figure1 (Figure1)

A plasma concentration versus time graph showing Nabumetone active metabolite (6MNA) plasma concentrations at steady state following once-daily dosing of Nabumetone at 1000 mg (n=31) and 2000 mg (n=12). The chart illustrates concentration decline over 70 hours with shaded bands representing ±2 standard deviations for both doses.*

FDA Label Image

Structure1 (Structure1)

Chemical structure diagram of nabumetone showing its molecular formula (C15H16O2) and molecular weight (228.3). The structure includes a naphthalene moiety with a methoxy group and an alkyl ketone side chain.*

FDA Label Image

Structure2 (Structure2)

Chemical structure of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of Nabumetone, showing the molecular arrangement of atoms including methoxy and carboxylic acid groups attached to a naphthalene ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.